Warning letter

Premier Pharmacy Labs Inc: warning letter of Apr 27, 2015

FDA warning letter 449477 · Florida District Office

Key facts

Reference number 449477
Company Premier Pharmacy Labs Inc
Subject Drug/Prepared, Packed or Held Under Insanitary Conditions/Adulterated
Issue date Apr 27, 2015
Posted date Jun 2, 2015
Issuing office Florida District Office
Product type Drugs
CFR sections cited 201.115, 211.192, 200.10(b), 211.28(a), 211.42(b), 211.42(c)(10)(iv), 211.42(c)(10)(vi), 211.94(d), 210.1(b)
Inspection city Weeki Wachee
Inspection ZIP 34613
Inspection start date Apr 10, 2014
Letter on fda.gov web.archive.org

At a glance

  • 1–9 CFR sections cited
  • OAI Linked inspection classification
  • Yes Form FDA 483 issued

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters